Review: taking Suboxone and Dilaudid together


Summary

Drug interactions are reported among people who take Suboxone and Dilaudid together. This review analyzes the effectiveness and drug interactions between Suboxone and Dilaudid. It is created by eHealthMe based on reports of 36 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Suboxone and Dilaudid >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Suboxone

Suboxone has active ingredients of buprenorphine hydrochloride; naloxone hydrochloride. It is often used in drug dependence. (latest outcomes from Suboxone 8,184 users)

Dilaudid

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. (latest outcomes from Dilaudid 10,026 users)

On Jul, 29, 2016

36 people who take Suboxone, Dilaudid are studied.


Number of reports submitted per year:

Suboxone and Dilaudid drug interactions.

Drug effectiveness over time:

Suboxone:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 100.0% - (2 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Dilaudid:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 100.0% - (2 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Suboxone:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (3 of 3 people)
Dilaudid:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (2 of 2 people)

Drug effectiveness by age:

Suboxone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (1 of 1 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 100.0% - (1 of 1 people)
Dilaudid:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (1 of 1 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 100.0% - (1 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • insomnia
  • nausea
  • nephrolithiasis
  • haematochezia
  • pain
  • drug ineffective
  • psychotic disorder
  • substance-induced psychotic disorder
1 - 6 months:
  • abdominal pain
  • cellulitis
  • hidradenitis
  • nausea
  • vomiting
  • anxiety
  • arthralgia
  • back pain
  • cardiac failure
  • dizziness
6 - 12 months:
  • nausea
  • pain
  • somnolence
  • convulsion
  • drug withdrawal syndrome
2 - 5 years:
  • abnormal behaviour
  • aggression
  • anxiety
  • coma
  • depression
  • metabolic acidosis
  • metabolic encephalopathy
  • suicide attempt
not specified:
  • arthralgia
  • insomnia
  • pain
  • cellulitis
  • back pain
  • drug dependence
  • nausea
  • depression
  • abdominal pain
  • alopecia

Most common drug interactions by gender *:

female:
  • insomnia
  • arthralgia
  • pain
  • cellulitis
  • nausea
  • abdominal pain
  • back pain
  • drug dependence
  • depression
  • alopecia
male:
  • hospitalisation
  • hypokinesia
  • malaise
  • vomiting
  • drug abuse
  • drug tolerance increased
  • drug withdrawal syndrome
  • grand mal convulsion
  • stress
  • decreased appetite

Most common drug interactions by age *:

20-29:
  • anhedonia
  • anxiety
  • injury
  • pain
  • pulmonary embolism
30-39:
  • abdominal pain
  • cellulitis
  • hidradenitis
  • nausea
  • vomiting
  • depression
  • insomnia
  • malaise
  • anaemia
  • constipation
40-49:
  • alopecia
  • arthralgia
  • bone pain
  • bronchitis
  • cellulitis
  • chest pain
  • depression
  • dysphagia
  • general physical health deterioration
  • influenza
50-59:
  • back pain
  • cardiac failure
  • dizziness
  • drug dependence
  • dyspnoea
  • nausea
  • pain
  • abdominal pain
  • anxiety
  • arthralgia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Suboxone and Dilaudid?

Can you answer these questions?

More questions for: Suboxone, Dilaudid

You may be interested in these reviews

More reviews for: Suboxone, Dilaudid

On eHealthMe, Suboxone (buprenorphine hydrochloride; naloxone hydrochloride) is often used to treat drug dependence. Dilaudid (hydromorphone hydrochloride) is often used to treat pain. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.